Abstract
Background: With the passing of the 2018 Agriculture Improvement Act that legalized hemp-derived products, i.e., cannabidiol (CBD), the use of CBD has increased exponentially. To date, the few studies that have characterized individuals who use CBD suggest that co-use of CBD and tetrahydrocannabinol (THC)-dominant cannabis, i.e., marijuana, is highly prevalent. It is, therefore, important to investigate the relationship between CBD use and marijuana use to understand the antecedents and consequences of co-use of these two cannabis products.Methods: We conducted an online survey using structured questionnaires to determine differences in CBD users with (CBD+MJ) and without co-morbid marijuana use. Group comparisons were carried out using chi-square tests and ANOVA. Multiple correspondence analysis (MCA) with bootstrap ratio testing was performed to examine the relationship between the categorical data.Results: We received 182 survey responses from current CBD users. CBD+MJ had more types of CBD administration (F = 17.07, p < 0.001) and longer lifetime duration of CBD use (χ2 = 12.85, p < 0.05). Results from the MCA yielded two statistically significant dimensions that accounted for 77% of the total variance. Dimension 1 (representing 57% of the variance) associated CBD+MJ with indication of CBD use for medical ailments, use of CBD for more than once a day for longer than 2 years, applying CBD topically or consuming it via vaping or edibles, being female, and, having lower educational attainment. Dimension 2 (representing 20% of the variance) separated the groups primarily on smoking-related behaviors where CBD+MJ was associated with smoking CBD and nicotine.Conclusions: Identifying the factors that influence use of CBD and marijuana can inform future studies on the risks and benefits associated with each substance as well as the impacts of policies related to cannabis-based products.
Highlights
METHODSThe cannabis sativa plant species contains a multitude of varieties, such as hemp and marijuana (MJ), with various active elements known as phyto-cannabinoids
Our results suggest that co-use of MJ in CBD users is associated with indication of CBD use for medical ailments, use of CBD
Regarding the medical ailments found in multiple correspondence analysis (MCA) dimension 1—anxiety, depression, physical pain, arthritis, migraines, and sleep disorders, we found that the presence of one ailment was associated with the possible presence of other ailments
Summary
METHODSThe cannabis sativa plant species contains a multitude of varieties, such as hemp and marijuana (MJ), with various active elements known as phyto-cannabinoids. Hemp was rescheduled from a DEA schedule I substance to a schedule V substance This reclassification identifies hemp and hemp-derived products, such as cannabidiol (CBD), as a substance of medicinal value with no addictive properties and legalizes it nationally. CBD’s appeal as a medicinal agent is based upon its favorable tolerance in both human and animal models [3,4,5] These models found a lack of habit-forming potential [6, 7] and rare incidents of adverse side-effects [8] from CBD use compared to THC [9,10,11]. The few studies that have characterized individuals who use CBD suggest that co-use of CBD and tetrahydrocannabinol (THC)-dominant cannabis, i.e., marijuana, is highly prevalent. Important to investigate the relationship between CBD use and marijuana use to understand the antecedents and consequences of co-use of these two cannabis products
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
